Send to a Friend Font Size: Increase Decrease

PHS and OSAKA Related Headlines

Mar 3, 2026 04:52AM Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions

PHS and OSAKA Related Press Releases

Mar 3, 2026 04:52AM Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions

PHS and OSAKA Related SEC Filings